Main > GASTROENTEROLOGY > USA. B. UC.>Treat>S1P Receptor>
USA. B. UC.>Treat>S1P Receptor>'s subsections
(*) CA Approval Date: 2022. 04.12
(*) EU CE Mark Date: 2021. 11.23.
(*) USA Approval Date: 2021. 05.27.
>Modulator Capsules
Company
Generic Name: Ozanimod Capsules
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 9
Patent>UpDate: 2021. 05.18.
RTM
RTM Web-Site
S1P: Sphingosine-1-Phosphate
USA. B. UC.>Treat>S1P Receptor>'s products
This section has no products